DAFNA Capital Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Hold |
|
|||||
|
2025
Q1 | $799K | Hold |
|
|||||
|
2024
Q4 | $1.44M | Sell |
|
|||||
|
2024
Q3 | $3.24M | Sell |
|
|||||
|
2024
Q2 | $4.64M | Sell |
|
|||||
|
2024
Q1 | $4.98M | Buy |
|
|||||
|
2023
Q4 | $1.47M | Sell |
|
|||||
|
2023
Q3 | $1.29M | Sell |
|
|||||
|
2023
Q2 | $1.1M | Buy |
|
|||||
|
2023
Q1 | $1.07M | Sell |
|
|||||
|
2022
Q4 | $1.95M | Sell |
|
|||||
|
2022
Q3 | $1.84M | Buy |
|
|||||
|
2022
Q2 | $98K | Hold |
|
|||||
|
2022
Q1 | $202K | Sell |
|
|||||
|
2021
Q4 | $757K | Buy |
|
|||||
|
2021
Q3 | $744K | Sell |
|
|||||
|
2021
Q2 | $756K | Sell |
|
|||||
|
2021
Q1 | $1.19M | Buy |
|
|||||
|
2020
Q4 | $1.04M | Sell |
|
|||||
|
2020
Q3 | $1.2M | Sell |
|
|||||
|
2020
Q2 | $1.62M | Buy |
|
|||||
|
2020
Q1 | $235K | Hold |
|
|||||
|
2019
Q4 | $339K | Hold |
|
|||||
|
2019
Q3 | $226K | Buy |
|
|||||
|
2019
Q2 | $340K | Sell |
|
|||||
|
2019
Q1 | $910K | Buy |
|
|||||
|
2018
Q4 | $358K | Sell |
|
|||||
|
2018
Q3 | $1M | Sell |
|
|||||
|
2018
Q2 | $1.67M | Buy |
|